Cargando…

Physical Fitness and Chemotherapy Tolerance in Patients with Early-Stage Breast Cancer

INTRODUCTION: An optimal relative dose intensity (RDI) of adjuvant chemotherapy is associated with better survival in patients with breast cancer. Little is known about the role of physical fitness in attaining an adequate RDI in patients with early-stage breast cancer. We investigated the associati...

Descripción completa

Detalles Bibliográficos
Autores principales: Groen, Wim G., Naaktgeboren, Willeke R., van Harten, Wim H., van Vulpen, Jonna K., Kool, Nathalie, Sonke, Gabe S., van der Wall, Elsken, Velthuis, Miranda J., Aaronson, Neil K., May, Anne M., Stuiver, Martijn M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920022/
https://www.ncbi.nlm.nih.gov/pubmed/34961754
http://dx.doi.org/10.1249/MSS.0000000000002828
_version_ 1784669040335126528
author Groen, Wim G.
Naaktgeboren, Willeke R.
van Harten, Wim H.
van Vulpen, Jonna K.
Kool, Nathalie
Sonke, Gabe S.
van der Wall, Elsken
Velthuis, Miranda J.
Aaronson, Neil K.
May, Anne M.
Stuiver, Martijn M.
author_facet Groen, Wim G.
Naaktgeboren, Willeke R.
van Harten, Wim H.
van Vulpen, Jonna K.
Kool, Nathalie
Sonke, Gabe S.
van der Wall, Elsken
Velthuis, Miranda J.
Aaronson, Neil K.
May, Anne M.
Stuiver, Martijn M.
author_sort Groen, Wim G.
collection PubMed
description INTRODUCTION: An optimal relative dose intensity (RDI) of adjuvant chemotherapy is associated with better survival in patients with breast cancer. Little is known about the role of physical fitness in attaining an adequate RDI in patients with early-stage breast cancer. We investigated the association between pretreatment physical fitness and RDI in this population. METHODS: We pooled individual patient data from two randomized exercise trials that studied exercise programs in early breast cancer: the Physical Exercise During Adjuvant Chemotherapy Effectiveness Study (n = 230) and the Physical Activity during Chemotherapy Treatment (n = 204) study. Logistic regression models were used to evaluate the association between pretreatment fitness and achieving an optimal RDI (≥85%). In addition, we added an interaction term to the model to explore the potential moderating effect of participating in an exercise program. RESULTS: Data were available for 419 patients (mean age at diagnosis, 50.0 ± 8.6 yr). In the total sample, lower pretreatment physical fitness was associated with significantly lower odds of achieving ≥85% RDI: age-adjusted odds ratio (OR) of 0.66 (95% confidence interval (CI), 0.46–0.94). In patients allocated to the supervised exercise intervention during chemotherapy (n = 173), the association between pretreatment physical fitness and RDI was almost completely mitigated (OR, 0.95 (95% CI, 0.54–1.56)), whereas it was more pronounced in patients who received care as usual (n = 172; OR, 0.31 (95% CI, 0.13–0.63); P(interaction) = 0.022). CONCLUSIONS: Early-stage breast cancer patients with relatively lower levels of pretreatment physical fitness have lower odds of achieving an optimal dose of chemotherapy. Given that physical fitness is modifiable and our results suggest that following a moderate-to-high intensity exercise training during chemotherapy could improve treatment completion, clinicians should not refrain from referring patients to supportive exercise programs because of low fitness.
format Online
Article
Text
id pubmed-8920022
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-89200222022-03-18 Physical Fitness and Chemotherapy Tolerance in Patients with Early-Stage Breast Cancer Groen, Wim G. Naaktgeboren, Willeke R. van Harten, Wim H. van Vulpen, Jonna K. Kool, Nathalie Sonke, Gabe S. van der Wall, Elsken Velthuis, Miranda J. Aaronson, Neil K. May, Anne M. Stuiver, Martijn M. Med Sci Sports Exerc Clinical Sciences INTRODUCTION: An optimal relative dose intensity (RDI) of adjuvant chemotherapy is associated with better survival in patients with breast cancer. Little is known about the role of physical fitness in attaining an adequate RDI in patients with early-stage breast cancer. We investigated the association between pretreatment physical fitness and RDI in this population. METHODS: We pooled individual patient data from two randomized exercise trials that studied exercise programs in early breast cancer: the Physical Exercise During Adjuvant Chemotherapy Effectiveness Study (n = 230) and the Physical Activity during Chemotherapy Treatment (n = 204) study. Logistic regression models were used to evaluate the association between pretreatment fitness and achieving an optimal RDI (≥85%). In addition, we added an interaction term to the model to explore the potential moderating effect of participating in an exercise program. RESULTS: Data were available for 419 patients (mean age at diagnosis, 50.0 ± 8.6 yr). In the total sample, lower pretreatment physical fitness was associated with significantly lower odds of achieving ≥85% RDI: age-adjusted odds ratio (OR) of 0.66 (95% confidence interval (CI), 0.46–0.94). In patients allocated to the supervised exercise intervention during chemotherapy (n = 173), the association between pretreatment physical fitness and RDI was almost completely mitigated (OR, 0.95 (95% CI, 0.54–1.56)), whereas it was more pronounced in patients who received care as usual (n = 172; OR, 0.31 (95% CI, 0.13–0.63); P(interaction) = 0.022). CONCLUSIONS: Early-stage breast cancer patients with relatively lower levels of pretreatment physical fitness have lower odds of achieving an optimal dose of chemotherapy. Given that physical fitness is modifiable and our results suggest that following a moderate-to-high intensity exercise training during chemotherapy could improve treatment completion, clinicians should not refrain from referring patients to supportive exercise programs because of low fitness. Lippincott Williams & Wilkins 2022-04 2021-12-27 /pmc/articles/PMC8920022/ /pubmed/34961754 http://dx.doi.org/10.1249/MSS.0000000000002828 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American College of Sports Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Sciences
Groen, Wim G.
Naaktgeboren, Willeke R.
van Harten, Wim H.
van Vulpen, Jonna K.
Kool, Nathalie
Sonke, Gabe S.
van der Wall, Elsken
Velthuis, Miranda J.
Aaronson, Neil K.
May, Anne M.
Stuiver, Martijn M.
Physical Fitness and Chemotherapy Tolerance in Patients with Early-Stage Breast Cancer
title Physical Fitness and Chemotherapy Tolerance in Patients with Early-Stage Breast Cancer
title_full Physical Fitness and Chemotherapy Tolerance in Patients with Early-Stage Breast Cancer
title_fullStr Physical Fitness and Chemotherapy Tolerance in Patients with Early-Stage Breast Cancer
title_full_unstemmed Physical Fitness and Chemotherapy Tolerance in Patients with Early-Stage Breast Cancer
title_short Physical Fitness and Chemotherapy Tolerance in Patients with Early-Stage Breast Cancer
title_sort physical fitness and chemotherapy tolerance in patients with early-stage breast cancer
topic Clinical Sciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920022/
https://www.ncbi.nlm.nih.gov/pubmed/34961754
http://dx.doi.org/10.1249/MSS.0000000000002828
work_keys_str_mv AT groenwimg physicalfitnessandchemotherapytoleranceinpatientswithearlystagebreastcancer
AT naaktgeborenwilleker physicalfitnessandchemotherapytoleranceinpatientswithearlystagebreastcancer
AT vanhartenwimh physicalfitnessandchemotherapytoleranceinpatientswithearlystagebreastcancer
AT vanvulpenjonnak physicalfitnessandchemotherapytoleranceinpatientswithearlystagebreastcancer
AT koolnathalie physicalfitnessandchemotherapytoleranceinpatientswithearlystagebreastcancer
AT sonkegabes physicalfitnessandchemotherapytoleranceinpatientswithearlystagebreastcancer
AT vanderwallelsken physicalfitnessandchemotherapytoleranceinpatientswithearlystagebreastcancer
AT velthuismirandaj physicalfitnessandchemotherapytoleranceinpatientswithearlystagebreastcancer
AT aaronsonneilk physicalfitnessandchemotherapytoleranceinpatientswithearlystagebreastcancer
AT mayannem physicalfitnessandchemotherapytoleranceinpatientswithearlystagebreastcancer
AT stuivermartijnm physicalfitnessandchemotherapytoleranceinpatientswithearlystagebreastcancer